Intellia Therapeutics, Inc. (NTLA): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001193125-26-448673

Filer

Intellia Therapeutics, Inc. (CIK 1652130)